In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study
ConclusionsSwitching between ESAs was frequent in both CKD and cancer patients. The number of cumulative transfusions and severity of disease seemed to affect the switch.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Chronic Kidney Disease | Databases & Libraries | Drugs & Pharmacology | Hyperparathyroidism | Iron | Italy Health | Study | Urology & Nephrology | Vitamin A | Vitamins